The predictive value of pre-treatment <sup>18</sup>F-FDG PET/CT on treatment outcome in early-stage extranodal natural killer/T-cell lymphoma.

Guo, Rui; Xu, Pengpeng; Xu, Haoping; Miao, Ying; Li, Biao

The predictive value of pre-treatment ¹⁸F-FDG PET/CT on treatment outcome in early-stage extranodal natural killer/T-cell lymphoma.

Guo, Rui; Xu, Pengpeng; Xu, Haoping; Miao, Ying; Li, Biao.

Afiliação

Guo R; Department of Nuclear Medicine, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.
Xu P; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai, China.
Xu H; Department of Radiation, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.
Miao Y; Department of Nuclear Medicine, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.
Li B; Department of Nuclear Medicine, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.

Leuk Lymphoma ; 61(11): 2659-2664, 2020 11.

Article em En | MEDLINE | ID: mdl-32573298

Assuntos

Infecções por Vírus Epstein-Barr; Linfoma de Células T; Fluordesoxiglucose F18; Glicólise; Herpesvirus Humano 4; Humanos; Células Matadoras Naturais; Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada; Prognóstico; Estudos Retrospectivos; Resultado do Tratamento; Carga Tumoral

Palavras-chave

18F-FDG PET/CT; ENKTL; early-stage; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T / Infecções por Vírus Epstein-Barr Tipo de estudo: Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google